BioAtla, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
Yahoo
MarketWatch
MarketWatch
CNBC
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.